MCK · Mckesson Corp
$907.99
-13.39 (-1.45%)
At close · Sep 4
Market Cap
$107.53B
Shares
116.59M
MCK metrics
83 of 114 screener metrics currently available.
Market overview
2 metricsShare price
$907.99
Market cap
$107.53B
Price action
19 metricsPrice change (1W)
+3.5%
Price change (30D)
+5.7%
Price change (3M)
+21.7%
Price change (6M)
-1.1%
Price change (YTD)
+12.3%
Price change (1Y)
+33.4%
Trailing year
Price change (5Y)
+346.7%
52-week high
$995.69
52-week low
$687.40
Change from 52-week high
-7.5%
Change from 52-week low
+34.0%
Annualized volatility
31.2%
Beta
-0.3
RSI (14D)
63.0
Price vs SMA 50
+9.1%
Price vs SMA 200
+9.3%
Avg volume (3M)
1.03M
Relative volume
0.8
Average dollar volume
$846.71M
Company
3 metricsSector
Healthcare
Industry
Medical Distribution
Shares outstanding
116.59M
Valuation
12 metricsP / E (TTM)
24.7
Trailing earnings · reciprocal yield 4.0%
PEG ratio
—
EV / revenue
—
EV / EBITDA
—
EV / EBIT
—
P / sales
0.3×
reciprocal yield 382.2%
P / book
—
FCF yield
6.0%
TTM · current market cap
Buyback yield
6.2%
P / FCF
16.8
reciprocal yield 6.0%
P / operating cash flow
15.7
reciprocal yield 6.4%
Earnings yield
4.3%
Historical valuation
8 metricsP / E historical average (3Y)
24.9×
reciprocal yield 4.0%
P / E historical average (5Y)
25.6×
reciprocal yield 3.9%
EV / revenue historical average (3Y)
0.2×
reciprocal yield 409.6%
EV / revenue historical average (5Y)
0.2×
reciprocal yield 458.5%
EV / EBIT historical average (3Y)
18.9×
reciprocal yield 5.3%
EV / EBIT historical average (5Y)
18.3×
reciprocal yield 5.5%
EV / EBITDA historical average (3Y)
—
EV / EBITDA historical average (5Y)
—
Dividends & buybacks
7 metricsDividend yield
0.4%
Trailing 12 months
Payout ratio
8.6%
Shareholder yield
6.6%
Dividend / share (TTM)
$3.40
Dividend growth YoY
+15.3%
Dividend growth streak
5
Last ex-dividend
2026-09-01
Earnings calendar
2 metricsNext earnings
—
Last earnings
2026-08-05
Profitability
9 metricsGross margin
3.6%
Operating margin
1.6%
Trailing 12 months
Net margin
1.1%
Gross profit (TTM)
$14.96B
Operating profit (TTM)
$6.50B
Net income (TTM)
$4.59B
Trailing 12 months
Diluted EPS (TTM)
$37.28
FCF margin
1.6%
Effective tax rate
17.9%
Growth
11 metricsRevenue growth YoY
+7.7%
Year over year
Net income growth YoY
-21.7%
Revenue (TTM)
$410.98B
Trailing 12 months
EPS growth YoY
-17.6%
Shares change YoY
-5.0%
Year over year · fewer shares
Revenue CAGR (3Y)
+13.4%
Revenue CAGR (5Y)
+11.1%
EPS CAGR (3Y)
+15.3%
EPS CAGR (5Y)
—
FCF CAGR (3Y)
+6.2%
FCF CAGR (5Y)
+6.9%
Quality
14 metricsReturn on equity
—
Return on assets
5.2%
Debt / equity
—
Current ratio
0.9
EBITDA (TTM)
—
Free cash flow (TTM)
$6.42B
Quick ratio
0.5
Interest coverage
23.6
Net debt / EBITDA
—
Return on invested capital
—
Trailing 12 months
Net cash
—
Latest balance sheet
Cash & equivalents
$5.16B
Total assets
$88.33B
Total debt
—
Cash flow & spend
7 metricsOperating cash flow (TTM)
$6.85B
Capital expenditures (TTM)
$437.00M
R&D (TTM)
—
SG&A (TTM)
$8.16B
Stock compensation (TTM)
—
R&D / revenue
—
Stock compensation / revenue
—
Ownership (13F)
3 metrics13F filers
2,013
13F filer change QoQ
-42
Institutional ownership
91.3%
Short interest
3 metricsShort interest
2.1%
Latest settlement · 2.2 days to cover
Days to cover
2.2d
Short-squeeze score
46 / 100
Insider activity
2 metricsNet insider buying (90D)
−$17.31M
Insider-sentiment score
54 / 100
Risk flags
1 metricsGoing concern
—
Key facts
CIK
927653
CUSIP
58155Q103
13F (30d)
1049 filings
994 filers
Visit website
Investor relations